203 related articles for article (PubMed ID: 35269900)
1. Regulation of Cell-Signaling Pathways by Berbamine in Different Cancers.
Farooqi AA; Wen R; Attar R; Taverna S; Butt G; Xu B
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269900
[TBL] [Abstract][Full Text] [Related]
2. Berbamine suppresses cell proliferation and promotes apoptosis in ovarian cancer partially via the inhibition of Wnt/β-catenin signaling.
Zhang H; Jiao Y; Shi C; Song X; Chang Y; Ren Y; Shi X
Acta Biochim Biophys Sin (Shanghai); 2018 Jun; 50(6):532-539. PubMed ID: 29701777
[TBL] [Abstract][Full Text] [Related]
3. Novel synthetic derivatives of the natural product berbamine inhibit Jak2/Stat3 signaling and induce apoptosis of human melanoma cells.
Nam S; Xie J; Perkins A; Ma Y; Yang F; Wu J; Wang Y; Xu RZ; Huang W; Horne DA; Jove R
Mol Oncol; 2012 Oct; 6(5):484-93. PubMed ID: 22717603
[TBL] [Abstract][Full Text] [Related]
4. A novel synthetic derivative of the natural product berbamine inhibits cell viability and induces apoptosis of human osteosarcoma cells, associated with activation of JNK/AP-1 signaling.
Yang F; Nam S; Zhao R; Tian Y; Liu L; Horne DA; Jove R
Cancer Biol Ther; 2013 Nov; 14(11):1024-31. PubMed ID: 24025361
[TBL] [Abstract][Full Text] [Related]
5. A novel berbamine derivative inhibits cell viability and induces apoptosis in cancer stem-like cells of human glioblastoma, via up-regulation of miRNA-4284 and JNK/AP-1 signaling.
Yang F; Nam S; Brown CE; Zhao R; Starr R; Ma Y; Xie J; Horne DA; Malkas LH; Jove R; Hickey RJ
PLoS One; 2014; 9(4):e94443. PubMed ID: 24732116
[TBL] [Abstract][Full Text] [Related]
6. CaMKII γ, a critical regulator of CML stem/progenitor cells, is a target of the natural product berbamine.
Gu Y; Chen T; Meng Z; Gan Y; Xu X; Lou G; Li H; Gan X; Zhou H; Tang J; Xu G; Huang L; Zhang X; Fang Y; Wang K; Zheng S; Huang W; Xu R
Blood; 2012 Dec; 120(24):4829-39. PubMed ID: 23074277
[TBL] [Abstract][Full Text] [Related]
7. Luteolin mediated targeting of protein network and microRNAs in different cancers: Focus on JAK-STAT, NOTCH, mTOR and TRAIL-mediated signaling pathways.
Farooqi AA; Butt G; El-Zahaby SA; Attar R; Sabitaliyevich UY; Jovic JJ; Tang KF; Naureen H; Xu B
Pharmacol Res; 2020 Oct; 160():105188. PubMed ID: 32919041
[TBL] [Abstract][Full Text] [Related]
8. Berbamine induces Fas-mediated apoptosis in human hepatocellular carcinoma HepG2 cells and inhibits its tumor growth in nude mice.
Wang GY; Lv QH; Dong Q; Xu RZ; Dong QH
J Asian Nat Prod Res; 2009; 11(3):219-28. PubMed ID: 19408145
[TBL] [Abstract][Full Text] [Related]
9. Berbamine: a novel inhibitor of bcr/abl fusion gene with potent anti-leukemia activity.
Xu R; Dong Q; Yu Y; Zhao X; Gan X; Wu D; Lu Q; Xu X; Yu XF
Leuk Res; 2006 Jan; 30(1):17-23. PubMed ID: 16023722
[TBL] [Abstract][Full Text] [Related]
10. Berbamine derivatives: a novel class of compounds for anti-leukemia activity.
Xie J; Ma T; Gu Y; Zhang X; Qiu X; Zhang L; Xu R; Yu Y
Eur J Med Chem; 2009 Aug; 44(8):3293-8. PubMed ID: 19285759
[TBL] [Abstract][Full Text] [Related]
11. EGCG Mediated Targeting of Deregulated Signaling Pathways and Non-Coding RNAs in Different Cancers: Focus on JAK/STAT, Wnt/β-Catenin, TGF/SMAD, NOTCH, SHH/GLI, and TRAIL Mediated Signaling Pathways.
Farooqi AA; Pinheiro M; Granja A; Farabegoli F; Reis S; Attar R; Sabitaliyevich UY; Xu B; Ahmad A
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32290543
[TBL] [Abstract][Full Text] [Related]
12. Berbamine Exerts Anti-Inflammatory Effects via Inhibition of NF-κB and MAPK Signaling Pathways.
Jia XJ; Li X; Wang F; Liu HQ; Zhang DJ; Chen Y
Cell Physiol Biochem; 2017; 41(6):2307-2318. PubMed ID: 28456802
[TBL] [Abstract][Full Text] [Related]
13. Interplay of long non-coding RNAs and TGF/SMAD signaling in different cancers.
Farooqi AA; Attar R; Qureshi MZ; Fayyaz S; Sohail MI; Sabitaliyevich UY; Nurmurzayevich SB; Yelekenova A; Yaylim I; Alaaeddine N
Cell Mol Biol (Noisy-le-grand); 2018 Dec; 64(15):1-6. PubMed ID: 30672446
[TBL] [Abstract][Full Text] [Related]
14. Berbamine Exerts an Anti-oncogenic Effect on Pancreatic Cancer by Regulating Wnt and DNA Damage-related Pathways.
Hu B; Yang Y; Tu J; Cai H; Yang S; Chen X; Chen G
Anticancer Agents Med Chem; 2023; 23(2):201-209. PubMed ID: 35579129
[TBL] [Abstract][Full Text] [Related]
15. 4-Chlorobenzoyl berbamine induces apoptosis and G2/M cell cycle arrest through the PI3K/Akt and NF-kappaB signal pathway in lymphoma cells.
Du HP; Shen JK; Yang M; Wang YQ; Yuan XQ; Ma QL; Jin J
Oncol Rep; 2010 Mar; 23(3):709-16. PubMed ID: 20127010
[TBL] [Abstract][Full Text] [Related]
16. Berbamine inhibits proliferation and induces apoptosis of KU812 cells by increasing Smad3 activity.
Liang Y; Qiu X; Xu RZ; Zhao XY
J Zhejiang Univ Sci B; 2011 Jul; 12(7):568-74. PubMed ID: 21726064
[TBL] [Abstract][Full Text] [Related]
17. Berbamine, a novel nuclear factor kappaB inhibitor, inhibits growth and induces apoptosis in human myeloma cells.
Liang Y; Xu RZ; Zhang L; Zhao XY
Acta Pharmacol Sin; 2009 Dec; 30(12):1659-65. PubMed ID: 19960011
[TBL] [Abstract][Full Text] [Related]
18. Berbamine exerts anticancer effects on human colon cancer cells via induction of autophagy and apoptosis, inhibition of cell migration and MEK/ERK signalling pathway.
Mou L; Liang B; Liu G; Jiang J; Liu J; Zhou B; Huang J; Zang N; Liao Y; Ye L; Liang H
J BUON; 2019; 24(5):1870-1875. PubMed ID: 31786849
[TBL] [Abstract][Full Text] [Related]
19. Cucurbitacin mediated regulation of deregulated oncogenic signaling cascades and non-coding RNAs in different cancers: Spotlight on JAK/STAT, Wnt/β-catenin, mTOR, TRAIL-mediated pathways.
Lin X; Farooqi AA
Semin Cancer Biol; 2021 Aug; 73():302-309. PubMed ID: 33152487
[TBL] [Abstract][Full Text] [Related]
20. Novel synthetic tosyl chloride-berbamine regresses lethal MYC-positive leukemia by targeting CaMKIIγ/Myc axis.
Yu Q; Wang P; Yang L; Wu Z; Li S; Xu Y; Wu B; Ma A; Gan X; Xu R
Biomed Pharmacother; 2019 Sep; 117():109134. PubMed ID: 31247466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
